ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

$20 Million In Construction Funds Approved

April 2, 1976

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

European Treatment Regimen Less Toxic Than American Method

April 26, 2013

Panel Resumes Deliberations

January 4, 1980

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975